Time-to-progression after front-line fludarabine, cyclophosphamide, and rituximab chemoimmunotherapy for chronic lymphocytic leukaemia: a retrospective, multicohort study

• 期刊名称The Lancet Oncology
• 作者Herling, Carmen D; Coombes, Kevin R; Benner, Axel; Bloehdorn, Johannes; Barron, Lynn L; Abrams, Zachary B; Majewski, Tadeusz; Bondaruk, Jolanta E; Bahlo, Jasmin; Fischer, Kirsten; Hallek, Michael; Stilgenbauer, Stephan; Czerniak, Bogdan A; Oakes, Christopher C; Ferrajoli, Alessandra; Keating, Michael J; Abruzzo, Lynne V
• 印刷ISSN1470-2045
• 文件大小2436.83KB
• 发表时间2019-9
• DOI10.1016/S1470-2045(19)30503-0